Filing Details
- Accession Number:
- 0001062993-21-011407
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-22 20:39:55
- Reporting Period:
- 2021-11-18
- Accepted Time:
- 2021-11-22 20:39:55
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1661181 | Organogenesis Holdings Inc. | ORGO | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1757452 | Gn 2016 Organo 10-Year Grat U/A/D September 30, 2016 | 35 Sawgrass Drive Bellport NY 11713 | No | No | Yes | No | |
1757453 | Gn 2016 Family Trust U/A/D August 12, 2016 | 35 Sawgrass Drive Bellport NY 11713 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Acquisiton | 2021-11-18 | 25,000 | $9.93 | 59,448,027 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The reported securities were purchased and held directly by Glenn H. Nussdorf, who is a member of the Group (as defined below).
- The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $9.89 to $9.95, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.
- Reflects the total number of securities held by the Group.